Perspective Therapeutics (CATX) Non-Current Deferred Tax Liability (2023 - 2026)

Perspective Therapeutics' Non-Current Deferred Tax Liability history runs 4 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• In Q1 2026, Non-Current Deferred Tax Liability fell 31.78% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (down 31.78% YoY), while the FY2025 annual figure was $1.7 million, down 31.78% from the prior year.
• Non-Current Deferred Tax Liability came in at $1.7 million for Q1 2026 at Perspective Therapeutics, roughly flat from $1.7 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $4.6 million in Q4 2023 to a low of $1.7 million in Q4 2025.
• A 4-year average of $3.2 million and a median of $2.5 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
• Across the five-year window, Non-Current Deferred Tax Liability tumbled 45.67% in 2024 and slumped 31.78% in 2025, its largest moves.
• Perspective Therapeutics' Non-Current Deferred Tax Liability stood at $4.6 million in 2023, then sank by 45.67% to $2.5 million in 2024, then sank by 31.78% to $1.7 million in 2025, then changed by 0.0% to $1.7 million in 2026.
• According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $1.7 million, $1.7 million, and $2.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison